Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-reveals-vasopressin-injection-can-reduce-risks-of-hysteroscopic-myomectomy
https://www.med.cuhk.edu.hk/press-releases/cuhk-reveals-vasopressin-injection-can-reduce-risks-of-hysteroscopic-myomectomy

CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

Submucous fibroids, a type of uterine fibroids, are usually treated with a surgery named hysteroscopic myomectomy. The Department of Obstetrics and Gynaecology at The Chinese University of Hong Kong (CUHK) recently revealed that direct injection of vasopressin to submucous fibroids before the operation of hysteroscopic myomectomy, can reduce the risk of fluid intravasation. This procedure can ensure complete tumour removal by enhancing surgical safety and effectiveness. 

 

Uterine fibroids is the most common type of benign tumor in women. In Hong Kong, about one in four women have uterine fibroids. Among the cases, 5% are classified as submucous fibroids, which may cause heavy menstrual bleeding and infertility. Hysteroscopic myomectomy is an ideal surgical treatment for submucous fibroids as it ensures satisfactory bleeding control, avoids any abdominal incision, and allows preservation of uterus and rapid recovery. 

 

Hysteroscopic myomectomy involves distention of the uterine cavity for adequate visualization of the operative field. As fluid is widely used as the distention medium, there is a risk of fluid intravasation which may lead to life-threatening hyponatremia, heart failure, pulmonary and cerebral edema. 

 

The Department of Obstetrics and Gynaecology at CUHK has been investigating a new technique of direct injection of vasopressin to submucous fibroids during hysteroscopy since 2010. Research results showed that the injection can greatly reduce the risk of fluid intravasation during operation. In order to verify the effectiveness of the technique, the Department conducted a double-blind randomized controlled trial from 2011 to 2014. 39 premenopausal women with symptomatic submucous fibroids were randomly separated into two groups: one receiving vasopressin injection and the other normal saline injection. The patients and operating surgeons were blinded to the allocated treatment. The result proved that direct vasopressin injection to submucous fibroids significantly reduced fluid intravasation and blood loss during operation. It also provided a better surgical visualization and efficiency (Table 1). 

 

Table 1

 

 Vasopressin Injection (20 ppl)Normal saline injection (19 ppl)
Operation Time20 minutes29minutes
Median volume of fluid used4200ml9800ml
Fluid intravasation0ml300ml
Blood loss rated as “Minimal”95%37%

 

Prof. Tak-yeung Leung, Chairman of the Department of Obstetrics and Gynaecology explained that vasopressin is commonly used during abdominal and laparoscopic myomectomy. Direct injection to submucous fibroids can reduce blood loss and fluid entry to circulation by its vaso-constrictive effect. ‘Fluid intravasation may lead to life threatening complications. Vasopressin injection not only lowers the surgical risk but also avoids incomplete resection due to fluid intravasation. Therefore, it enhances the effectiveness of the operation.’ 

 

Dr. Chun-wai Cheung, Clinical Associate Professor (Honorary), Department of Obstetrics and   Gynaecology stated, ‘According to researches, preoperative gonadotropin-releasing hormone agonist (GnRHa) can be prescribed one to three months prior to the surgery to lower the risk of fluid intravasation. However, the cost of GnRHa is relatively high and it may lead to side effects including menopausal symptoms, delay in surgical procedures and difficult cervical dilatation. Comparing to GnRHa, vasopressin does not have these effects.’ Dr. Cheung reminded that patients with vascular disease, epilepsy, migraine, asthma or heart failure are not suitable for vasopressin injection. 

 

Dr. Alyssa Sze-wai Wong, Clinical Assistant Professor (Honorary), Department of Obstetrics and Gynaecology concluded that the study is groundbreaking which proves that direct vasopressin injection to submucous fibroids can enhance the safety and effectiveness of hysteroscopic myomectomy. ‘By further improving the surgical effectiveness, we hope the new technique would help us treat larger submucous fibroids in future, benefiting more patients.’

 

Prof. Leung Tak Yeung, Chairman; Dr. Cheung Chun Wai, Clinical Associate Professor

(From right) Prof. Leung Tak Yeung, Chairman; Dr. Cheung Chun Wai, Clinical Associate Professor (Honorary); and Dr. Wong Sze Wai, Clinical Assistant Professor (Honorary) from the Department of Obstetrics and Gynaecology, CUHK present the research findings on vasopressin injection prior Hysteroscopic Myomectomy.

The hysteroscopy and ovum aspiration needle

The hysteroscopy and ovum aspiration needle, holding by Dr. Wong Sze Wai, Clinical Assistant Professor (Honorary), Department of Obstetrics and Gynaecology, CUHK (Left), enable direct injection of vasopressin to Submucous fibroids . The injection can reduce the risk of fluid intravasation during Hysteroscopic Myomectomy.

 

More Press Releases

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

Research
CUHK-Baylor Study Proves Aspirin Reduces the Risk of Preeclampsia by Decelerating the Metabolic Clock of Gestation

CUHK-Baylor Study Proves Aspirin Reduces the Risk of Preeclampsia by Decelerating the Metabolic Clock of Gestation

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

Research
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

Research
CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

Research
CUHK Studies Alert Mothers to Pregnancy Weight Gain

CUHK Studies Alert Mothers to Pregnancy Weight Gain

Research
CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

Donation
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

Donation
CUHK Introduces Hong Kong's First Fragile X Carrier Screening

CUHK Introduces Hong Kong's First Fragile X Carrier Screening

Clinical service
CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

International collaboration
CUHK Launches Non-invasive Prenatal Test for Down Syndrome 15 Years of Research Comes to Fruition

CUHK Launches Non-invasive Prenatal Test for Down Syndrome 15 Years of Research Comes to Fruition

Research
CUHK Pioneers DNA Chip for Prenatal Diagnosis in HK

CUHK Pioneers DNA Chip for Prenatal Diagnosis in HK

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.